Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cardiac ventricle is one of the primary muscular chambers of the heart. There are two ventricles in mammals—one on the left, one on the right—that perform distinct roles: the left ventricle pumps oxygenated blood into the high-pressure systemic circulation, while the right ventricle pumps blood into the lower-pressure pulmonary circuit[2]. The structure and physiological properties of ventricular myocardium have been studied extensively, with significant variation in myoarchitecture (compact, trabeculated, or mixed forms)[1]. Molecularly, cardiac function is coordinated by numerous proteins expressed in ventricular myocytes, including ion channels and contractile apparatus components[2]. However, the ventricle itself is not a protein, receptor, or other conventional drug target but rather a vital organ segment, so drug actions are mediated by molecular targets within ventricular tissue (such as sodium, potassium, and calcium channels; beta-adrenergic receptors; etc.)[2][3]. Developmental processes shaping ventricular formation involve molecular signals like Notch, Neuregulin, Ephrin, BMP10, and transcription factors such as NKX2-5, MEF2C, and GATA4, but these operate within cells of the ventricle, not the ventricle as a molecular entity[3][4]. Ventricles play central roles in cardiovascular disease pathogenesis and progression, with dysfunction manifesting as heart failure, arrhythmia, and remodeling[2][3]. In summary, "cardiac ventricle" is an anatomical structure, not a druggable molecular target, and information mapped to structured target lists should note this as an anatomical term with no canonical molecular target entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac ventricle.